The expression of the tight junction protein and therapeutical target Claudin 18.2 is heterogeneously distributed within esophageal and gastric adenocarcinoma.

Sci Rep · 2025 · PMC12332122 · PMID 40775258

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

showed a trendp = 0.02actually significant

In GAC, CLDN18.2 expression showed a trend towards less invasive growth ( p = 0.02) and less common lymph node metastasis ( p = 0.07) and was more often observed within the EBV-associated subtype ( p = 0.01).

also in 16,965 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.